412
Views
10
CrossRef citations to date
0
Altmetric
Brief Communication

Neurotoxicity associated with exposure to 1-bromopropane in golf-club cleansing workers

, , , , , , & show all
Pages 823-826 | Received 07 Dec 2014, Accepted 17 Jun 2015, Published online: 10 Jul 2015
 

Abstract

Background. 1-Bromopropane (1-BP) is an alternative to ozone-depleting solvent that is used in degreasing, dry cleaning, spray adhesives, and aerosol solvents. Occupational exposure to 1-BP is associated with adverse peripheral sensory, motor, and central nervous system (CNS) effects. We report our Health Hazard and Medical Evaluation of 6 patients with neurotoxicity associated with occupational exposure to 1-BP. Case series and environmental evaluation. Six workers, 1 male and 5 female, were exposed to high ambient 1-BP concentrations while employed in a golf club cleaning factory. 1-BP was identified in the bulk solvent sample used by the workers and confirmed the workers’ daily occupational exposure to 1-BP for 3–10 months. The major presenting symptoms were tingling pain, soreness in lower extremities, and paresthesia. N-acetyl-S-(n-propyl)-L-cysteine (AcPrCys), a 1-BP metabolite, was identified by LC/MS/MS in the urine (0.171–1.74 mg/g-Cr) of these workers 5–26 days following 1-BP exposure. Discussion and conclusion. An occupational outbreak of 1-BP poisoning occurred as a result of recurrent power outages, condenser, and exhaust fans malfunction, and inadequate personal protection. Occupational exposure to 1-BP may result in peripheral neuropathy as well as adverse CNS effects. Urine AcPrCys may be a specific biomarker for 1-BP exposure.

Acknowledgments

The authors deeply feel grateful for the grants supported by the Ministry of Health and Welfare, Taiwan (M03A2085; MOHW-TD-M-111-5). We also appreciate the research approval granted by the Institutional Review Board of Taipei Veterans General Hospital, Taiwan (VGHIRB No. 2013-12-021CC).

Declaration of interest

The authors report no declaration of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.